ABL Bio Inc Financial Flexibility Index
ABL Bio Inc financial flexibility index. ABL Bio Inc (298380) has a Financial Flexibility Index of -0.23x as of June 2026. Free cash flow of ₩-22.86 Billion (operating CF ₩-23.42 Billion minus capex ₩552.62 Million) represents 0% of total liabilities (₩99.78 Billion). Explore 298380 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ABL Bio Inc (2016–2025)
Financial flexibility index of ABL Bio Inc from 2016 to 2025. Historical Financial Flexibility Index trend for ABL Bio Inc across 10 annual periods. Check how aggressively does ABL Bio Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
ABL Bio Inc Financial Flexibility Index by Year (2016–2025)
ABL Bio Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for ABL Bio Inc. For the full cash flow conversion analysis, see ABL Bio Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | ₩-20.58 Billion | ₩-41.25 Billion | ₩124.24 Billion | ▲ +82.2% |
| 2024 | -0.93x | ₩-60.34 Billion | ₩-69.40 Billion | ₩64.70 Billion | ▼ -256.5% |
| 2023 | -0.26x | ₩-22.52 Billion | ₩-28.36 Billion | ₩86.07 Billion | ▼ -140.8% |
| 2022 | 0.64x | ₩74.19 Billion | ₩72.13 Billion | ₩115.67 Billion | ▲ +115.5% |
| 2021 | -4.14x | ₩-39.36 Billion | ₩-40.61 Billion | ₩9.50 Billion | ▲ +18.4% |
| 2020 | -5.08x | ₩-46.86 Billion | ₩-47.29 Billion | ₩9.23 Billion | ▼ -148.4% |
| 2019 | -2.04x | ₩-22.26 Billion | ₩-23.86 Billion | ₩10.89 Billion | ▼ -111.3% |
| 2018 | -0.97x | ₩-11.52 Billion | ₩-12.67 Billion | ₩11.91 Billion | ▼ -1522.3% |
| 2017 | -0.06x | ₩-6.34 Billion | ₩-7.14 Billion | ₩106.32 Billion | ▼ -18.7% |
| 2016 | -0.05x | ₩-985.97 Million | ₩-3.12 Billion | ₩19.63 Billion | — |